ClinicalTrials.gov
public full text
Public Domain
Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer
RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for ovarian cancer. PURPOSE: Screening trial to determine the significance of cancer antigen 125 (CA125) levels in detecting ovarian cancer in participants who have a high genetic risk of developing ovarian cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Screening Women at High Genetic Risk for Ovarian Cancer#865850
- Ovarian Screening Study#900570
- Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women#897736
- Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors#892920
- A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer#883432
Record · ID 1010186
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive